))
Episode 23 - Professor John McNeil: can aspirin slow the progression of dementia?
Archived series ("Inactive feed" status)
When?
This feed was archived on March 24, 2016 13:02 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 62473960 series 41854
Content provided by Dr Ian McDonald. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Ian McDonald or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
A large trial is currently underway in Australia and USA involving around 19,000 elderly participants investigating whether a daily aspirin can prolong a healthy lifespan, through the prevention of thing such as heart attack, stroke, cognitive decline, physical decline and some cancers. Known as the ASPREE study, which stands for (Aspirin Reducing Events in the Elderly) it is one of the most important high-quality, large-scale cohort studies that will provide a large evidence base on the effects of long term aspirin use. While this study is aiming to answer many questions and theories, one of the major research questions which has recently received some media attention is can regular aspirin use delay the onset of dementia? In this episode I am pleased to be chatting with one of the Australian project leaders – Professor John McNeill from Monash University who is involved in answering this question.
You can find out more about ASPREE here.
31 episodes
Share
